146 related articles for article (PubMed ID: 6163159)
1. Further experience in testing the sensitivity of human ovarian carcinoma cells to interferon in an in vitro semisolid agar culture system: comparison of solid and ascitic forms of the tumor.
Epstein LB; Shen JT; Abele JS; Reese CC
Prog Clin Biol Res; 1980; 48():277-90. PubMed ID: 6163159
[TBL] [Abstract][Full Text] [Related]
2. Review of experience with interferon and drug sensitivity testing of ovarian carcinoma in semisolid agar culture.
Epstein LB; Marcus SG
Cancer Chemother Pharmacol; 1981; 6(3):273-7. PubMed ID: 6172214
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity of human ovarian carcinoma cells to interferon and other antitumor agents as assessed by an in vitro semi-solid agar technique.
Epstein LB; Shen JT; Abele JS; Reese CC
Ann N Y Acad Sci; 1980; 350():228-44. PubMed ID: 6165278
[TBL] [Abstract][Full Text] [Related]
4. In vitro drug testing of ovarian cancer using the human tumor colony-forming assay: comparison of in vitro response and clinical outcome.
Federico M; Alberts DS; Garcia DJ; Emerson J; Fanta P; Liu R; Salmon SE
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S156-63. PubMed ID: 7835801
[TBL] [Abstract][Full Text] [Related]
5. Development of a bioassay for ovarian carcinoma colony-forming cells.
Hamburger AW; Salmon SE; Alberts DS
Prog Clin Biol Res; 1980; 48():63-73. PubMed ID: 7208527
[TBL] [Abstract][Full Text] [Related]
6. Limitations of drug sensitivity testing in soft agar for clinical management of patients with ovarian carcinoma.
Arbuck SG; Pavelic ZP; Piver MS; Slocum HK; Malfetano J; Gamarra M; Rustum YM
Obstet Gynecol; 1985 Jul; 66(1):115-20. PubMed ID: 3892385
[TBL] [Abstract][Full Text] [Related]
7. Antiproliferative actions of tamoxifen to human ovarian carcinomas in vitro.
Lazo JS; Schwartz PE; MacLusky NJ; Labaree DC; Eisenfeld AJ
Cancer Res; 1984 Jun; 44(6):2265-71. PubMed ID: 6722767
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
[TBL] [Abstract][Full Text] [Related]
9. Analysis of human ascites effect on clonogenic growth of human tumor cell lines and NRK-49F cells in soft agar.
Broxterman HJ; Sprenkels-Schotte C; Engelen P; Leyva A; Pinedo HM
Int J Cell Cloning; 1987 Mar; 5(2):158-69. PubMed ID: 3572052
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity of clonogenic cells of human ovarian ascitic cancer to antitumor drugs.
Potapov SL; Korman DB; Shamaev VI; Ershova RB; Makarov OV
Arch Geschwulstforsch; 1988; 58(2):99-104. PubMed ID: 3377653
[TBL] [Abstract][Full Text] [Related]
11. Effect of fibroblast, lymphoid, and myeloid interferons on human tumor colony formation in vitro.
Bradley EC; Ruscetti FW
Cancer Res; 1981 Jan; 41(1):244-9. PubMed ID: 6160905
[TBL] [Abstract][Full Text] [Related]
12. [Sensitivity of clonogenic cells of human ascitic ovarian cancer to antitumor agents].
Potapov SL; Korman DB; Shamaev VI; Ershova RB; Makarov OV
Eksp Onkol; 1987; 9(4):47-50. PubMed ID: 3678125
[TBL] [Abstract][Full Text] [Related]
13. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-2 expanded lymphocytes from lymph node and tumor biopsies of human renal cell carcinoma, breast and ovarian cancer.
Bouet-Toussaint F; Genetel N; Rioux-Leclercq N; Bansard JY; Levêque J; Guillé F; Patard JJ; Lesimple T; Catros-Quemener V
Eur Cytokine Netw; 2000 Jun; 11(2):217-24. PubMed ID: 10903800
[TBL] [Abstract][Full Text] [Related]
15. Modulation of human tumor colony growth in soft agar by serum.
Hamburger AW; White CP; Dunn FE; Citron ML; Hummel S
Int J Cell Cloning; 1983 Sep; 1(4):216-29. PubMed ID: 6366083
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacokinetic study of intraperitoneal chemotherapy with high-dose cisplatin for advanced ovarian cancer].
Deng C; Huang R; Lian L
Zhonghua Fu Chan Ke Za Zhi; 1996 Mar; 31(3):159-62. PubMed ID: 8758790
[TBL] [Abstract][Full Text] [Related]
17. Comparison of antigen expression on fresh and cultured ascites cells and on solid tumors of patients with epithelial ovarian cancer.
Provencher DM; Finstad CL; Saigo PE; Rubin SC; Hoskins WJ; Federici MG; Stockert E; Lloyd KO; Lewis JL
Gynecol Oncol; 1993 Jul; 50(1):78-83. PubMed ID: 8349167
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a cell line derived from the ascites of a patient with papillary serous cystadenocarcinoma of the ovary.
Wilson AP
J Natl Cancer Inst; 1984 Mar; 72(3):513-21. PubMed ID: 6583437
[TBL] [Abstract][Full Text] [Related]
19. [The comparison of biological characteristics between tumor-infiltrating lymphocytes and tumor-associated lymphocytes in ascites of epithelial ovarian carcinoma].
Kang S; Shen K; Lang J
Zhonghua Fu Chan Ke Za Zhi; 1998 Oct; 33(10):607-10. PubMed ID: 10806687
[TBL] [Abstract][Full Text] [Related]
20. Comparison of cellular phenotypes in tumor cyst and ascitic fluid from ovarian serous carcinoma.
Harlozinska A; Bar JK; Richter R; Cislo M
Acta Cytol; 1992; 36(6):869-74. PubMed ID: 1449024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
